Vitamin B1 (Thiamine) Market Size, Share, Growth, and Industry Analysis, By Type (Food Grade,Feed Grade,Pharmaceutical Grade), By Application (Pharmaceutical Industry,Food Industry,Feed Industry), Regional Insights and Forecast to 2035
Vitamin B1 (Thiamine) Market Overview
The global Vitamin B1 (Thiamine) Market size is projected to grow from USD 1257.04 million in 2026 to USD 1326.69 million in 2027, reaching USD 2042.39 million by 2035, expanding at a CAGR of 5.54% during the forecast period.
The global Vitamin B1 (Thiamine) market is a crucial segment within the broader vitamin and nutritional supplement industry. In 2024, the market size was estimated at approximately 12.82 thousand tonnes, reflecting its significant role in human health and nutrition. Thiamine is essential for energy metabolism and nerve function, leading to its widespread use in dietary supplements, fortified foods, and pharmaceuticals. The market's expansion is driven by increasing consumer awareness of nutritional health and the importance of vital vitamins. In 2024, the global thiamine market size was estimated at approximately 12.82 thousand tonnes, with a projected growth trajectory indicating a significant rise in demand across diverse industries.
In the United States, the demand for Vitamin B1 (Thiamine) is influenced by factors such as dietary habits, health consciousness, and regulatory frameworks. The U.S. market for thiamine is bolstered by its extensive use in the pharmaceutical and nutraceutical sectors, where it is utilized in the formulation of supplements and medications aimed at addressing thiamine deficiencies and supporting overall health. The prevalence of health-related concerns and the growing inclination towards preventive healthcare contribute to the sustained demand for thiamine-based products in the U.S. market.
Key Findings
- Driver: Approximately 65% of the market growth is attributed to the rising demand for dietary supplements and fortified foods, driven by increasing health awareness among consumers.
- Major Market Restraint: Around 25% of market challenges stem from stringent regulatory standards and certification requirements, which can impede market entry and product development.
- Emerging Trends: The market is witnessing a 15% increase in the adoption of plant-based and vegan thiamine supplements, reflecting a shift towards plant-derived nutrients.
- Regional Leadership: Asia-Pacific leads the market with a 40% share, propelled by rapid urbanization and dietary changes in countries like China and India.
- Competitive Landscape: Approximately 30% of the market share is held by top players such as BASF and DSM, indicating a concentrated competitive environment.
- Market Segmentation: The market is segmented into food grade, feed grade, and pharmaceutical grade, with food grade accounting for 50% of the market share.
- Recent Development: A notable 20% increase in thiamine fortification in staple foods has been observed, aiming to combat nutritional deficiencies in developing regions.
Vitamin B1 (Thiamine) Market Trends
The Vitamin B1 (Thiamine) market is experiencing several notable trends that are shaping its development. One significant trend is the increasing consumer preference for natural and organic sources of thiamine, leading to a surge in demand for plant-based supplements. This shift is driven by growing health consciousness and a desire for clean-label products. Additionally, advancements in biotechnology have facilitated the production of thiamine through fermentation processes, enhancing yield and purity.
The pharmaceutical industry is also witnessing a rise in the incorporation of thiamine in formulations aimed at addressing neurological disorders, reflecting its therapeutic potential. Moreover, regulatory bodies are implementing stricter guidelines on food fortification, prompting manufacturers to innovate and comply with new standards. These trends collectively contribute to the dynamic evolution of the Vitamin B1 (Thiamine) market.
Vitamin B1 (Thiamine) Market Dynamics
DRIVER
Rising demand for pharmaceuticals.
The pharmaceutical industry's increasing reliance on thiamine for the development of treatments for conditions such as beriberi and Wernicke-Korsakoff syndrome is a primary driver of market growth. Thiamine's essential role in nerve function and energy metabolism makes it a critical component in various therapeutic formulations. The growing prevalence of neurological disorders and the emphasis on preventive healthcare are further propelling the demand for thiamine-based pharmaceutical products.
RESTRAINT
"Demand for refurbished equipment."
The growing preference for refurbished equipment in the manufacturing of thiamine can pose challenges related to quality control and production efficiency. While refurbished equipment may offer cost savings, it may not always meet the stringent standards required for the production of high-quality thiamine. This can lead to concerns regarding product consistency and safety, potentially affecting market growth.
OPPORTUNITY
"Growth in personalized medicines."
The rise of personalized medicine presents significant opportunities for the Vitamin B1 (Thiamine) market. As healthcare shifts towards tailored treatments based on individual genetic profiles, the demand for specific nutrient formulations, including thiamine, is expected to increase. This trend opens avenues for the development of customized thiamine supplements and therapies, catering to the unique needs of patients.
CHALLENGE
"Rising costs and expenditures."
The escalating costs associated with raw materials and production processes pose challenges to the Vitamin B1 (Thiamine) market. Fluctuations in the prices of precursor chemicals and energy can impact manufacturing expenses, potentially leading to higher prices for end products. These cost pressures may affect the affordability and accessibility of thiamine-based products, particularly in price-sensitive markets.
Vitamin B1 (Thiamine) Market Segmentation
BY TYPE
Food Grade":" thiamine is primarily utilized in the fortification of staple foods such as rice, flour, and cereals to prevent deficiencies in populations. The demand for food-grade thiamine is driven by regulatory mandates in many countries requiring fortification in staple foods, ensuring widespread consumption and sustained market demand.
The Food Grade Vitamin B1 (Thiamine) segment is projected to hold a market size of USD 420.34 million in 2025, capturing a 35.3% share of the global market, with an estimated CAGR of 5.2% through 2034.
Top 5 Major Dominant Countries in the Food Grade Segment
- United States: The U.S. Food Grade Vitamin B1 market is valued at USD 98.6 million in 2025, accounting for 23.5% share, growing steadily with a CAGR of 5.4% led by fortified food demand.
- China: China dominates with USD 92.4 million market size in 2025, achieving a 22% share and maintaining a CAGR of 5.6%, driven by strong food fortification programs.
- Germany: Germany contributes USD 55.1 million in 2025, representing 13.1% share, with an expected CAGR of 5.1%, led by demand for functional food and beverages.
- India: India’s Food Grade Vitamin B1 market is valued at USD 44.3 million in 2025, holding a 10.5% share, advancing with a CAGR of 5.7%, supported by rice fortification programs.
- Brazil: Brazil reports USD 39.9 million market size in 2025, with 9.5% share and a CAGR of 5.3%, driven by expansion in fortified bakery and dairy sectors.
Feed Grade":" thiamine is incorporated into animal feed to promote growth and health in livestock. The increasing demand for meat and dairy products globally is driving the need for high-quality animal feed, thereby boosting the demand for feed-grade thiamine.
The Feed Grade Vitamin B1 (Thiamine) segment is forecasted to achieve a market size of USD 372.85 million in 2025, representing 31.3% share of the total market, growing at a CAGR of 5.7% through 2034.
Top 5 Major Dominant Countries in the Feed Grade Segment
- China: China leads the Feed Grade segment at USD 103.5 million in 2025, holding a 27.7% share with a CAGR of 5.9%, fueled by large-scale livestock and aquaculture industries.
- United States: The U.S. market is valued at USD 81.9 million in 2025, representing 22% share and advancing with a CAGR of 5.5%, supported by rising feed supplementation.
- India: India posts USD 58.1 million in 2025, capturing 15.6% share, with a CAGR of 5.8%, driven by poultry and dairy industry growth.
- Brazil: Brazil records USD 52.7 million in 2025, taking 14.1% share with a CAGR of 5.4%, reflecting increasing animal nutrition demand.
- Germany: Germany achieves USD 46.4 million in 2025, covering 12.4% share, with a CAGR of 5.3%, supported by advanced animal husbandry practices.
Pharmaceutical Grade":" thiamine is used in the production of medications and supplements aimed at treating thiamine deficiencies and related conditions. The growing prevalence of neurological disorders and the emphasis on preventive healthcare are propelling the demand for pharmaceutical-grade thiamine.
The Pharmaceutical Grade Vitamin B1 (Thiamine) segment is projected at USD 397.87 million in 2025, commanding a 33.4% share of the global market, expanding at a CAGR of 5.8% until 2034.
Top 5 Major Dominant Countries in the Pharmaceutical Grade Segment
- United States: The U.S. leads at USD 110.3 million in 2025, contributing 27.7% share with a CAGR of 6.0%, reflecting strong dietary supplement and therapeutic demand.
- Germany: Germany posts USD 72.6 million in 2025, with 18.2% share and CAGR of 5.6%, driven by rising thiamine deficiency treatments.
- China: China holds USD 70.4 million in 2025, representing 17.7% share, and maintains a CAGR of 5.7%, supported by robust pharmaceutical production.
- Japan: Japan contributes USD 65.2 million in 2025, accounting for 16.4% share, with a CAGR of 5.8%, owing to a high prevalence of dietary supplement use.
- India: India achieves USD 56.1 million in 2025, capturing 14.1% share, and expands at a CAGR of 5.9%, bolstered by growing healthcare and preventive medicine demand.
BY APPLICATION
Pharmaceutical Industry":" thiamine is utilized in the formulation of supplements and medications aimed at addressing thiamine deficiencies and supporting overall health. The increasing prevalence of health-related concerns and the growing inclination towards preventive healthcare contribute to the sustained demand for thiamine-based products in the pharmaceutical sector.
The Pharmaceutical Industry application segment is valued at USD 495.8 million in 2025, commanding 41.6% share of the total market with a CAGR of 5.8%.
Top 5 Major Dominant Countries in the Pharmaceutical Industry Application
- United States: U.S. Pharmaceutical application holds USD 142.6 million in 2025, 28.8% share, expanding with a CAGR of 6.0%, due to strong supplement market.
- Germany: Germany reports USD 91.7 million in 2025, 18.5% share, with CAGR of 5.7%, driven by therapeutic vitamin use.
- China: China secures USD 88.3 million in 2025, representing 17.8% share, advancing at CAGR of 5.9%, with rising deficiency prevention programs.
- Japan: Japan contributes USD 86.1 million in 2025, 17.3% share, with CAGR of 5.8%, supported by nutraceutical growth.
- India: India posts USD 87.1 million in 2025, 17.6% share, expanding with CAGR of 5.9%, driven by healthcare spending.
Food Industry":" incorporates thiamine into various products to enhance their nutritional value. Thiamine is added to staple foods such as cereals, bread, and energy drinks to address widespread nutrient deficiencies. The growing consumer demand for fortified foods is driving the incorporation of thiamine in the food industry.
The Food Industry application segment is projected at USD 392.6 million in 2025, holding 32.9% share of the market, with a CAGR of 5.4%.
Top 5 Major Dominant Countries in the Food Industry Application
- United States: U.S. Food Industry application valued at USD 99.1 million in 2025, 25.2% share, growing at CAGR of 5.5%, supported by fortified cereals and bakery.
- China: China secures USD 96.4 million in 2025, 24.5% share, with CAGR of 5.6%, driven by flour fortification.
- India: India records USD 76.3 million in 2025, 19.4% share, with CAGR of 5.7%, focused on fortified staples.
- Germany: Germany achieves USD 64.9 million in 2025, 16.5% share, with CAGR of 5.3%, reflecting functional food demand.
- Brazil: Brazil reports USD 55.9 million in 2025, 14.2% share, with CAGR of 5.4%, driven by fortified dairy and confectionery.
Feed Industry":" In the feed industry, thiamine is added to animal feed to promote growth and health in livestock. The increasing demand for meat and dairy products globally is driving the need for high-quality animal feed, thereby boosting the demand for thiamine in the feed industry.
The Feed Industry application segment is forecast at USD 302.6 million in 2025, representing 25.4% share of the global market, with a CAGR of 5.6%.
Top 5 Major Dominant Countries in the Feed Industry Application
- China: China leads with USD 89.1 million in 2025, 29.4% share, and CAGR of 5.9%, fueled by livestock demand.
- United States: U.S. Feed Industry accounts for USD 74.7 million in 2025, 24.7% share, advancing with CAGR of 5.5%, driven by cattle feed.
- India: India reports USD 58.2 million in 2025, 19.2% share, growing with CAGR of 5.7%, led by poultry expansion.
- Brazil: Brazil achieves USD 47.3 million in 2025, 15.6% share, expanding at CAGR of 5.4%, reflecting dairy and aquaculture growth.
- Germany: Germany posts USD 33.3 million in 2025, 11.1% share, with CAGR of 5.2%, supported by animal health awareness.
Vitamin B1 (Thiamine) Market Regional Outlook
NORTH AMERICA
holds a significant share of the global Vitamin B1 (Thiamine) market, driven by the high demand for dietary supplements and fortified foods. The presence of major pharmaceutical companies and a well-established healthcare infrastructure contribute to the region's market dominance.
The North America Vitamin B1 (Thiamine) market is projected at USD 372.1 million in 2025, holding 31% share, with a 5.5% CAGR, supported by pharmaceutical and food fortification sectors.
North America - Major Dominant Countries in the Vitamin B1 (Thiamine) Market
- United States: Leads with USD 249.8 million in 2025, securing 67% share at 5.6% CAGR, driven by pharmaceutical formulations and food supplements.
- Canada: Records USD 58.2 million with 16% share at 5.4% CAGR, boosted by functional food and fortified dairy products.
- Mexico: Expected at USD 42.7 million with 12% share at 5.3% CAGR, influenced by feed fortification and nutritional supplement demand.
- Cuba: Accounts for USD 11.0 million with 3% share at 5.2% CAGR, supported by health programs.
- Dominican Republic: Secures USD 10.4 million with 2% share at 5.1% CAGR, mainly food industry driven.
EUROPE
is a key market for Vitamin B1 (Thiamine), with increasing consumer awareness regarding nutritional health and the importance of essential vitamins. The region's stringent regulatory standards and emphasis on food fortification drive the demand for thiamine in various applications.
The Europe Vitamin B1 (Thiamine) market is estimated at USD 285.4 million in 2025, holding 24% share, with a 5.3% CAGR through 2034, supported by food fortification laws and strong pharmaceutical demand.
Europe - Major Dominant Countries in the Vitamin B1 (Thiamine) Market
- Germany: Leads with USD 74.2 million in 2025, capturing 26% share at 5.2% CAGR, driven by food fortification policies and pharmaceutical applications.
- United Kingdom: Records USD 59.7 million with 21% share at 5.3% CAGR, supported by fortified cereals and supplements.
- France: Achieves USD 52.4 million with 18% share at 5.1% CAGR, driven by rising vitamin intake in functional foods.
- Italy: Secures USD 49.2 million with 17% share at 5.4% CAGR, influenced by dietary supplement penetration.
- Spain: Holds USD 38.8 million with 14% share at 5.3% CAGR, supported by food fortification in flour and rice.
ASIA-PACIFIC
leads the global Vitamin B1 (Thiamine) market, accounting for a substantial share. Rapid urbanization, dietary changes, and a growing focus on health and wellness contribute to the region's market leadership. Countries like China and India are significant consumers and producers of thiamine.
The Asia Vitamin B1 (Thiamine) market is projected at USD 414.6 million in 2025, commanding 35% share, growing at a 5.8% CAGR, driven by fortified foods, supplements, and rising livestock feed requirements.
Asia - Major Dominant Countries in the Vitamin B1 (Thiamine) Market
- China: Dominates with USD 165.1 million in 2025, holding 40% share at 5.9% CAGR, supported by high deficiency prevalence and demand in pharmaceuticals.
- India: Records USD 91.8 million with 22% share at 5.8% CAGR, driven by government food fortification programs and supplement industry growth.
- Japan: Achieves USD 72.4 million with 17% share at 5.5% CAGR, influenced by demand in elderly healthcare and functional foods.
- South Korea: Holds USD 50.2 million with 12% share at 5.7% CAGR, driven by supplements and fortified beverages.
- Indonesia: Secures USD 35.1 million with 9% share at 5.6% CAGR, supported by feed and fortified food consumption.
MIDDLE EAST & AFRICA
region is experiencing growth in the Vitamin B1 (Thiamine) market, driven by increasing health awareness and the adoption of fortified foods. The region's expanding population and improving healthcare infrastructure contribute to the market's development.
The Middle East and Africa Vitamin B1 (Thiamine) market is valued at USD 118.9 million in 2025, representing 10% share, with a 5.2% CAGR, influenced by healthcare reforms and fortified staple food programs.
Middle East and Africa - Major Dominant Countries in the Vitamin B1 (Thiamine) Market
- Saudi Arabia: Leads with USD 35.1 million in 2025, capturing 30% share at 5.3% CAGR, driven by fortified wheat flour initiatives.
- South Africa: Accounts for USD 26.3 million with 22% share at 5.2% CAGR, supported by growing supplement demand.
- United Arab Emirates: Records USD 21.9 million with 18% share at 5.4% CAGR, supported by functional food industry.
- Egypt: Secures USD 19.0 million with 16% share at 5.1% CAGR, influenced by fortification of staple foods.
- Nigeria: Holds USD 16.6 million with 14% share at 5.0% CAGR, supported by rising nutritional supplement demand.
List of Top Vitamin B1 (Thiamine) Companies
- Brother Enterprises
- Xinfa Pharmaceutical
- Tianxin Pharmaceutical
- Tianjin Golden World Group
- BASF
- DSM
Brother Enterprises: is among the leading players in the global Vitamin B1 (Thiamine) market, holding an estimated 18% market share in 2024. The company is recognized for its large-scale production of pharmaceutical-grade and feed-grade thiamine, supplying more than 4,200 tonnes annually to over 50 countries.
Xinfa Pharmaceutical: ranks second in the Vitamin B1 (Thiamine) industry, with a market share of about 15% in 2024. The company produces nearly 3,600 tonnes annually, serving both domestic and international markets.
Investment Analysis and Opportunities
The Vitamin B1 (Thiamine) market presents significant investment opportunities, particularly in the development of plant-based and vegan supplements, which are gaining popularity among health-conscious consumers. Investments in research and development to enhance the bioavailability and stability of thiamine can lead to innovative products with improved efficacy.
Additionally, expanding production capacities in emerging markets can tap into the growing global demand for fortified foods, dietary supplements, and animal feed. In 2024, Asia-Pacific accounted for approximately 40% of the global Vitamin B1 (Thiamine) market, making it a key region for strategic investments. Manufacturers are increasingly focusing on vertical integration to control raw material quality and ensure consistent supply, while also investing in automation to enhance production efficiency. The rising adoption of e-commerce platforms and B2B distribution networks further facilitates market expansion. Investments in sustainability initiatives, such as eco-friendly fermentation processes for thiamine production, are also gaining traction, supporting long-term growth and aligning with global environmental standards.
New Product Development
The Vitamin B1 (Thiamine) market has witnessed notable innovations in recent years. Companies are introducing high-potency thiamine formulations, with doses ranging from 50 mg to 500 mg per serving, catering to both preventive and therapeutic applications. In 2024, approximately 60% of new product launches focused on combination supplements, integrating thiamine with other B vitamins to improve energy metabolism and cognitive function.
Fermentation-based thiamine production has increased by 25%, enhancing purity levels to above 99.5% for pharmaceutical-grade applications. Additionally, manufacturers have developed microencapsulated forms of thiamine for improved stability in fortified foods and beverages, with around 35% of products in the functional food segment utilizing these innovations. Functional beverages containing 10–50 mg of thiamine per serving are also growing in popularity in North America and Europe, driven by health-conscious consumers.
Five Recent Developments
- BASF's High-Stability Thiamine Launch (2023): BASF introduced a high-stability thiamine variant with 99.7% purity, targeting pharmaceutical and fortified food applications.
- DSM's Plant-Based Fermentation Line (2024): DSM launched a plant-based fermentation thiamine line, increasing bioavailability by 20% for dietary supplements.
- Xinfa Pharmaceutical's Production Capacity Expansion (2023): Xinfa Pharmaceutical expanded its production capacity by 15% to meet growing demand in Asia-Pacific markets.
- Brother Enterprises' Microencapsulated Thiamine Development (2024): Brother Enterprises developed microencapsulated thiamine for beverage fortification, now implemented in over 200 functional drinks.
- Tianjin Golden World Group's Eco-Friendly Fermentation Investment (2025): Tianjin Golden World Group invested in eco-friendly fermentation processes, reducing energy consumption by 18% for feed-grade thiamine.
Report Coverage of Vitamin B1 (Thiamine) Market
The Vitamin B1 (Thiamine) market report offers a comprehensive analysis of global and regional trends, market segmentation, competitive landscape, and growth opportunities. It covers production, consumption, and demand patterns for food grade, feed grade, and pharmaceutical grade thiamine across key regions including North America, Europe, Asia-Pacific, and the Middle East & Africa. The report provides detailed insights into applications in the pharmaceutical, food, and feed industries, as well as emerging trends such as plant-based supplements, fortified functional foods, and combination vitamin products.
Additionally, it highlights recent innovations, investment opportunities, and strategic developments by leading market players, providing stakeholders with actionable intelligence for decision-making. Market insights encompass product launches, technological advancements, and regulatory influences, ensuring a holistic understanding of the Vitamin B1 (Thiamine) market dynamics and opportunities for growth.
Vitamin B1 (Thiamine) Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 1257.04 Million in 2026 |
|
|
Market Size Value By |
USD 2042.39 Million by 2035 |
|
|
Growth Rate |
CAGR of 5.54% from 2026-2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Vitamin B1 (Thiamine) Market is expected to reach USD 2042.39 Million by 2035.
The Vitamin B1 (Thiamine) Market is expected to exhibit a CAGR of 5.54% by 2035.
Brother Enterprises,Xinfa Pharmaceutical,Tianxin Pharmaceutical,Tianjin Golden World Group,BASF,DSM.
In 2026, the Vitamin B1 (Thiamine) Market value stood at USD 1257.04 Million.